.@AOC to drug company CEO: Why is the price of Copaxone so much higher for people with multiple sclerosis in the United States than those in other countries? pic.twitter.com/GAjT73PwxA— Public Citizen (@Public_Citizen) September 30, 2020
.@AOC to drug company CEO: Why is the price of Copaxone so much higher for people with multiple sclerosis in the United States than those in other countries? pic.twitter.com/GAjT73PwxA